Literature DB >> 10322382

Coated dosage forms for colon-specific drug delivery.

.   

Abstract

Coating materials used in the manufacture of colon-specific solid oral dosage forms include polymers with a pH-dependent solubility that rely on the difference in pH between the small and the distal large intestine (pH-controlled release), polymers with a slow or pH-dependent rate of swelling, dissolution or erosion that take advantage of the constant small intestinal transit time (time-controlled release), polymers that are degradable by the microbial enzymes in the colon (enzyme-controlled release) and polymers that form firm layers that are destroyed by an increase of the luminal pressure in the colon caused by peristaltic waves (pressure-controlled release). This review gives an overview of coated dosage forms that have been developed to achieve colon specificity.

Year:  1999        PMID: 10322382     DOI: 10.1016/s1461-5347(99)00151-0

Source DB:  PubMed          Journal:  Pharm Sci Technolo Today        ISSN: 1461-5347


  9 in total

1.  Enteric coated magnetic HPMC capsules evaluated in human gastrointestinal tract by AC biosusceptometry.

Authors:  Luciana A Corá; Fernando G Romeiro; Fabiano C Paixão; Madileine F Américo; Ricardo B Oliveira; Oswaldo Baffa; José Ricardo A Miranda
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

Review 2.  Advances in colonic drug delivery.

Authors:  Abdul W Basit
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Sustained release tablets containing soluble polymethacrylates: comparison with tableted polymethacrylate IPEC polymers.

Authors:  Wasfy M Obeidat; Alaa H Abuznait; Al-Sayed A Sallam
Journal:  AAPS PharmSciTech       Date:  2010-01-07       Impact factor: 3.246

4.  Coatings of Eudragit® RL and L-55 Blends: Investigations on the Drug Release Mechanism.

Authors:  Robert Wulff; Claudia S Leopold
Journal:  AAPS PharmSciTech       Date:  2015-08-12       Impact factor: 3.246

5.  Chronomodulated drug delivery system of salbutamol sulphate for the treatment of nocturnal asthma.

Authors:  J Qureshi; Mohd Amir; Alka Ahuja; Sanjula Baboota; J Ali
Journal:  Indian J Pharm Sci       Date:  2008 May-Jun       Impact factor: 0.975

6.  Fixed Dose Single Tablet Formulation with Differential Release of Amlodipine Besylate and Simvastatin and Its Pharmacokinetic Profile: QbD and Risk Assessment Approach.

Authors:  Ummarah Kanwal; Shahid Mukhtar; Muzzamil Waheed; Arifa Mehreen; Nasir Abbas; Rahat Shamim; Khalid Hussain; Fatima Rasool; Amjad Hussain; Nadeem Irfan Bukhari
Journal:  Drug Des Devel Ther       Date:  2021-05-24       Impact factor: 4.162

7.  Formulation Development and Evaluation of Drug Release Kinetics from Colon-Targeted Ibuprofen Tablets Based on Eudragit RL 100-Chitosan Interpolyelectrolyte Complexes.

Authors:  Kenneth Chibuzor Ofokansi; Franklin Chimaobi Kenechukwu
Journal:  ISRN Pharm       Date:  2013-08-06

8.  Development of Colorectal-Targeted Dietary Supplement Tablets Containing Natural Purple Rice Bran Oil as a Colorectal Chemopreventive.

Authors:  Busaban Sirithunyalug; Chalermpong Saenjum; Suporn Charumanee; Bhagavathi Sundaram Sivamaruthi; Chaiyavat Chaiyasut; Jakkapan Sirithunyalug; Pratchaya Tipduangta
Journal:  Nutrients       Date:  2018-04-04       Impact factor: 5.717

Review 9.  Enteric-Coated Strategies in Colorectal Cancer Nanoparticle Drug Delivery System.

Authors:  Nasrul Wathoni; An Ny Nguyen; Agus Rusdin; Abd Kakhar Umar; Ahmed Fouad Abdelwahab Mohammed; Keiichi Motoyama; I Made Joni; Muchtaridi Muchtaridi
Journal:  Drug Des Devel Ther       Date:  2020-10-21       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.